The nitric oxide synthesis/pathway mediates the inhibitory serotoninergic responses of the pressor effect elicited by sympathetic stimulation in diabetic pithed rats

European Journal of Pharmacology

Volumn 537, Issue 1-3, 2006, Pages 126-134

  García, Mónica ^a   Morán, Asunción ^a   Luisa Martín, María ^a   Barthelmebs, Mariette ^b   San Román, Luis ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b INSERM   (France)

Author keywords

5 HT1A receptors; 5 hydroxytryptamine; Experimental diabetes; Nitric oxide; Prejunctional inhibition

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ALLOXAN; ARGININE; ATROPINE; GUANYLATE CYCLASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SEROTONIN; SEROTONIN 1A AGONIST;

ADRENERGIC STIMULATION; ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE VARIABILITY; CONTROLLED STUDY; ELECTROSTIMULATION; HYPERTENSION; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; SPINAL ANIMAL; SYMPATHETIC FUNCTION; SYMPATHETIC REFLEX; SYMPATHETIC TONE;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ATROPINE; BLOOD PRESSURE; DIABETES MELLITUS, EXPERIMENTAL; ELECTRIC STIMULATION; ENZYME INHIBITORS; GUANYLATE CYCLASE; MALE; MUSCARINIC ANTAGONISTS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOREPINEPHRINE; OXADIAZOLES; QUINOXALINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SEROTONIN AGONISTS; SPINAL CORD; TRYPTAMINES; VASOCONSTRICTION;

EID: 33646126720     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.03.020     Document Type: Article

References (53)

1. Abebe W., and Mcleod K.M. Protein kinase C-mediated contractile responses of arteries from diabetic rats. Br. J. Pharmacol. 101 (1990) 465-471
2. Agrawal D.K., Bhimji S., and Mcneill J.H. Effect of chronic experimental diabetes on vascular smooth muscle function in rabbit carotid artery. J. Cardiovasc. Pharmacol. 9 (1987) 584-593
3. Andersson D., Brunkwall J., Bergqvist D., and Edvinsson E. Diminished contractile responses to neuropeptide Y of arteries from diabetic rats. J. Auton. Nerv. Syst. 37 (1992) 215-222
4. Barradas M.A., Gills D.S., Fonseca V.A., Mikhailidis D.P., and Dandona P. Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease. Eur. J. Clin. Investig. 18 (1988) 399-404
5. 1D receptor agonist. Br. J. Pharmacol. 110 (1993) 1196-1200
6. Bhardwaj R., and Moore P.K. Increased vasodilator response to acetylcholine of renal blood vessels from diabetic rats. J. Pharm. Pharmacol. 40 (1988) 739-742
7. Bryan-Lluka L.J., Papacostas M.H., Paczkowski F.A., and Wanstall J.C. Nitric oxide donors inhibit 5-HT uptake in the human 5-HT transporter (SERT). Br. J. Pharmacol. 143 (2004) 63-70
8. Chan N.N., Vallance P., and Colhoun H.M. Nitric oxide and vascular responses in type I diabetes. Diabetologia 43 (2000) 1137-1147
9. +-ATPase in the aorta from rats with endotoxic shock. Shock 23 (2005) 179-185
10. Choi K.C., Kim N.H., An M.R., Kang D.G., Kim S.W., and Lee J. Alterations of intrarenal renin-angiotensin and nitric oxide systems in streptozotocin diabetic rats. Diabetologia 39 (1997) 793-799
11. Cohen R.A. Dysfunction of vascular endothelium in diabetes mellitus. Circulation 87 (1993) V67-V76
12. De Vriese A.S., Verbeuren T.J., Van De Voorde J., Lameire N.H., and Vanhoutte P.M. Endothelial dysfunction in diabetes. Br. J. Pharmacol. 130 (2000) 963-974
13. El Kasef H. Hyperglycaemia increased the responsiveness of isolated rabbit's pulmonary arterial rings to serotonin. Pharmacology 53 (1996) 151-159
14. 1 receptor antagonists. J. Auton. Pharmacol. 20 (2000) 313-323
15. Fitzgerald S.M., and Brands M.W. Nitric oxide may be required to prevent hypertension at the onset of diabetes. Am. J. Physiol. 279 (2000) E762-E768
16. García M., Morán A., Calama E., Martín M.L., Barthelmebs M., and San Román L. Diabetes-induced changes in the 5-hydroxytryptamine inhibitory receptors involved in the pressor effect elicited by sympathetic stimulation in the pithed rat. Br. J. Pharmacol. 145 (2005) 593-601
17. Gillespie J.S., and Muir J.C. A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in the pithed rat. Br. J. Pharmacol. Chemother. 30 (1967) 78-87
18. Gimeno G., Carpentier P.H., Desquand-Biliald S., Hanf R., and Finet M. l-arginine and NG-nitro-l-arginine methyl ester cause macromolecule extravasation in the microcirculation of awake hamsters. Eur. J. Pharmacol. 346 (1998) 275-282
19. Heygate K.M., Laurence I.G., Bennett M.A., and Thurston H. Impaired endothelium-dependent relaxation in isolated resistance arteries of spontaneously diabetic rats. Br. J. Pharmacol. 116 (1995) 3251-3259
20. Heygate K.M., Davies J., Holmes M., James R.F.L., and Thurston H. The effect of insulin treatment and of islet transplantation on the resistance artery function in the streptozotocin-induced diabetic rat. Br. J. Pharmacol. 119 (1996) 495-504
21. 2 receptor stimulation in the alloxan diabetic rats. J. Pharm. Pharmacol. 42 (1990) 423-427
22. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., and Humphrey P.P. International Union of Pharmacology classification of receptors of 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46 (1994) 157-203
23. Ireland S.J., and Jordan C.C. Pharmacological characterization of 5-hydroxytryptamine-induced hyperpolarization of the rat superior cervical ganglion. Br. J. Pharmacol. 92 (1987) 417-427
24. Ishida T., Kawashima S., Hirata K., and Yokoyama M. Nitric oxide is produced via 5-HT1B and 5-HT2B receptor activation in human coronary artery endothelial cells. Kobe J. Med. Sci. 44 (1998) 51-63
25. 2 receptor-mediated responses in hindquarters of diabetic rats. Eur. J. Pharmacol. 294 (1995) 109-115
26. 1D receptors mediate inhibition of sympathetic ganglionic transmission in anaesthetized cats. Br. J. Pharmacol. 116 (1995) 1715-1717
27. Komers R., and Anderson S. Paradoxes of nitric oxide in the diabetic kidney. Am. J. Physiol., Renal Physiol. 284 (2003) F1121-F1137
28. Martin F.J., Míguez J.M., Aldegunde M., and Atienza G. Effect of streptozotocin-induced diabetes mellitus on serotonin measures of peripheral tissues in rats. Life Sci. 56 (1995) 51-59
29. Mayhan W.C., and Patel K.P. Treatment with dimethylthiourea prevents impaired dilatation of the basilar artery during diabetes mellitus. Am. J. Physiol. 274 (1998) H1895-H1901
30. McDuffie J.E., Coaxum S.D., and Maleque M.A. 5-Hydroxytryptamine evokes endothelial nitric oxide synthase activation in bovine aortic endothelial cell cultures. Proc. Soc. Exp. Biol. Med. 221 (1999) 386-390
31. 1 recognition site. Eur. J. Pharmacol. 90 (1983) 151-153
32. Miranda F.J., Alabadi J.A., Llorens S., Ruiz De Apodaca R.F., Centeno J.M., and Alborch E. Diabetes-induced changes in endothelial mechanisms implicated in rabbit carotid arterial response to 5-hydroxytryptamine. Eur. J. Pharmacol. 401 (2000) 397-402
33. Miranda F.J., Alabadi J.A., Llorens S., Ruiz De Apodaca R.F., Centeno J.M., and Alborch E. Experimental diabetes induces hyperreactivity of rabbit renal artery to 5-hydroxytryptamine. Eur. J. Pharmacol. 439 (2002) 121-127
34. Molderings G.J., Fink K., Schlicker E., and Göthert M. Inhibition of noradrenaline release via presynaptic 5-HT1B receptors of the rat vena cava. Naunyn-Schmiedeberg's Arch. Pharmacol. 336 (1987) 245-250
35. Morán A., Velasco C., Salvador T., Martín M.L., and San Román L. Inhibitory 5-hydroxytryptamine receptors involved in pressor effects obtained by stimulation of sympathetic outflow from spinal cord in pithed rats. Br. J. Pharmacol. 113 (1994) 1358-1362
36. 1 receptors that mediate the inhibition of pressor effects elicited by sympathetic stimulation in the pithed rats. Br. J. Pharmacol. 123 (1998) 1205-1213
37. Palmer R.M., Ashton D.S., and Moncada S. Vascular endothelial cells synthesize NO from l-arginine. Nature 333 (1988) 664-666
38. Palmer R.M., Ashton D.S., and Moncada S. l-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun. 153 (1988) 1251-1256
39. Pieper G.M., Dembry K., and Siebeneich W. Long-term treatment in vivo with NOX-101, a scavenger of nitric oxide, prevents diabetes-induced endothelial dysfunction. Diabetologia 41 (1998) 1220-1226
40. Pieper G.M., Adams M.B., and Roza A.M. Pancreatic transplantation reverses endothelial dysfunction in experimental diabetes. Surgery 123 (1998) 89-95
41. Ralevic V., Belai A., and Burnstock G. Impaired sensory-motor nerve function in the isolated mesenteric arterial bed of streptozotocin-diabetic and ganglioside-treated streptozotocin-diabetic rats. Br. J. Pharmacol. 110 (1993) 1105-1111
42. Ralevic V., Belai A., and Burnstock G. Effects of streptozotocin-diabetes on sympathetic nerve, endothelial and smooth muscle function in the rat mesenteric arterial bed. Eur. J. Pharmacol. 296 (1995) 193-199
43. Rees D.D., Palmer R.M., Schulz R., Hodson H.F., and Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101 (1990) 746-752
44. 2 receptors in the rat brain. Life Sci. 60 (1997) 1393-1397
45. 1D receptor subtype. J. Pharmacol. Exp. Ther. 252 (1990) 387-395
46. Takiguchi Y., Satoh N., Hashimoto H., and Nakashima M. Changes in vascular reactivity in experimental diabetic rats: comparison with hypothyroid rats. Blood Vessels 25 (1988) 250-260
47. Taylor P.D., Oon B.B., Thomas C.R., and Poston L. Prevention by insulin treatment of endothelial dysfunction but not enhanced noradrenaline-induced contractility in mesenteric resistance arteries from streptozotocin-induced diabetic rats. Br. J. Pharmacol. 111 (1994) 35-41
48. Tolins J.P., Shultz P.J., Raij L., Brown D.M., and Mauer S.M. Abnormal renal haemodynamic response to reduced renal perfusion pressure in diabetic rats: role of the NO. Am. J. Physiol. 265 (1993) F886-F895
49. Tousoulis D., Tentolouris C., Crake T., Katsimaglis G., Stefanadis C., Toutouzas P., and Davies G.J. Effects of l- and d-arginine on the basal tone of human diseased coronary arteries and their responses to substance P. Heart (Bristish Cardiac Society) 81 (1999) 505-511
50. Villalón C.M., Contreras J., Ramirez-San Juan E., Castillo C., Perusquia M., Lopez-Munoz F.J., and Terron J.A. 5-hydroxytryptamine inhibits pressor responses to preganglionic sympathetic nerve stimulation in pithed rats. Life Sci. 57 (1995) 803-812
51. Villalón C.M., Contreras J., Ramirez-San Juan E., Castillo C., Perusquía M., and Terrón J.A. Characterization of prejunctional 5-HT receptors mediating inhibition of sympathetic vasopressor responses in the pithed rats. Br. J. Pharmacol. 116 (1995) 3330-3336
52. Villalón C.M., Contreras J., Ramírez-San Juan E., and Terrón J.A. 5-HT receptors mediating inhibition of pressor responses to electrical sympathetic stimulation in pithed rats. Br. J. Pharmacol. 114 (1995) 161
53. 1D subtypes. Br. J. Pharmacol. 124 5 (1998) 1001-1011